Vienna, Austria

ESTRO 2025

Session

Normal tissue radiobiology
Digital Poster
Radiobiology
Advanced Imaging and AI Techniques for Early Detection of Radiation Dermatitis: Feature-Based vs. Deep Learning Models
Iosif Strouthos, Cyprus
E25-439
Impaired DNA double-strand breaks repair in Friedreich’s Ataxia fibroblasts
Rafka Challita, Lebanon
E25-2735
Lipoxin A4 Mitigates Radiation-Induced Pulmonary Injury by Modulating Macrophage Polarization
Jaeho Cho, Korea Republic of
E25-2829
Cellular responses in murine salivary glands to fractionated irradiation: implications for fibrosis and hyposalivation
Inga Solgard Juvkam, Norway
E25-2917
Co-incidence of significant coronary calcifications in patients with radiotherapy-associated valvular disease
Andreas Spannbauer , Austria
E25-3278
Simulating carbon ions-induced microvascular damage using a microvasculature-on-chip model
Luca Possenti, Italy
E25-3399
Dental Erosion as a Potential Amplifier of Radiation Therapy-Induced Effects on Dental Enamel
Harley Oliveira, Brazil
E25-3530
The normal tissue protection of ultra-high electron dose rates increases with average dose rate and is reduced by dose splitting
Elke Beyreuther, Germany
E25-3698
Microbeam Radiotherapy in Liver Tissue: Radiobiological Insights into Mechanisms of Normal Tissue Sparing
Cheuk Ting Wu, Switzerland
E25-3739
External validation and updating of prediction model for Xerostomia in a local quality registry cohort
Emmy Dalqvist, Sweden
E25-3977
expression of tenascin-c is upregulated in the early stages of radiation pneumonitis/fibrosis in a novel mouse model
Kazuki Omori, Japan
E25-4064
The Role of Tenascin C as an Early Detection Marker for Radiation-Induced Cardiotoxicity and the Impact of Melatonin Dosage-in vivo rat study
H Fazilet Dinçbaş, Turkey
E25-453
Physicochemical Indication of the FLASH Effect from Shoot-through Proton Pencil Beam Scanning Parameters Delivered under Ultra-high Dose Rates
Andrew Friberg, USA
E25-4232
Ultra-hypofractionated for whole breast/chest wall adjuvant radiotherapy, acute toxicity, risk of late toxicity and tumor control probability.
Cheikh Tayeb, Algeria
E25-4258
Effects of extremely low dose hyperthermia neutron irradiation on the immune function of healthy mice
Ruiping Guo, China
E25-4319
Recovery calculations for reirradiation: what are the implications of choosing one method over another?
Esme Votta, United Kingdom
E25-4324
Radiobiology investigation on low-intensity neutron beam using zebrafish embryo model
Hideghety Katalin, Hungary
E25-4326
Progress of Laser-Driven Particle Beams at Extreme Light Infrastructure (ELI) Facilities
Hideghety Katalin, Hungary
E25-4347
Discordance in the induction of the FLASH effect between synchrotron-based proton and linac-based electron ultra-high dose rate irradiation
Kevin Liu, USA
E25-914
A novel method for defining subgroups of breast cancer patients with different risk of fibrosis after radiotherapy
Carsten Herskind, Germany
E25-1418
hippocampal dose exposure in nasopharyngeal cancer patients treated with modulated volumetric arc therapy (vmat)
Yasmine Daghfous, Tunisia
E25-1549
Dosimetric parameters of radiation-induced optic neuropathy based on visual field perimetry in patients undergoing proton therapy
Thao-Nguyen Pham, France
E25-1738
Radiobiological effects of laser-driven VHEE in vitro, ex vivo and in vivo assays
Camilla Giaccaglia, France
E25-1862
Endogenous hydrogen sulphide-responsive and depleting polyoxometalates alleviates radiation-induced enteritis
Jie Zhou, China
E25-2593
Optimizing blood-brain barrier modulation with low-dose fractionated radiotherapy for effective CNS antibody delivery
Peijing Li, China
E25-2601